Three monthly intravitreal bevacizumab injections resulted in significant reduction in central foveal thickness and improvements in BCVA in diabetic macular edema patients. Both 1.25 mg and 2.5 mg seemed to have similar treatment efficacy.

This is the first cytopathological study objectively indicating low likelihood of the postulation that retrocapsular lens matter occurred after uneventful phacoemulsification.

No abstract

The co-inhabitation of these two low-virulence organisms seems to represent an interesting symbiosis with boosting virulence and resistance to host defense, especially in those immunocompromised.